Assignee
EURAND INC
US·7 granted patents·6 pending applications·104 citations·filing 2003–2011
Top patents by PatentIndex Score
13 records- 0196US7544372B2Modified release dosage forms of skeletal muscle relaxantsEURAND INC·Filed 2008·Granted Jun 9, 2009·20 cites·21 claims
- 0296US7387793B2Modified release dosage forms of skeletal muscle relaxantsEURAND INC·Filed 2003·Granted Jun 17, 2008·51 cites·20 claims
- 0393US7829121B2Modified release dosage forms of skeletal muscle relaxantsEURAND INC·Filed 2008·Granted Nov 9, 2010·7 cites·28 claims
- 0493US7790199B2Modified release dosage forms of skeletal muscle relaxantsEURAND INC·Filed 2008·Granted Sep 7, 2010·7 cites·14 claims
- 0589US7919115B2Orally disintegrating tablet compositions of lamotrigineEURAND INC·Filed 2008·Granted Apr 5, 2011·11 cites·13 claims
- 0682US7820203B2Modified release dosage forms of skeletal muscle relaxantsEURAND INC·Filed 2008·Granted Oct 26, 2010·6 cites·12 claims
- 0762US7632521B2Controlled release potassium chloride tabletsEURAND INC·Filed 2003·Granted Dec 15, 2009·2 cites·27 claims
- 0856US2007190145A1Drug delivery systems comprising weakly basic selective serotonin 5-ht3 blocking agent and organic acidsEURAND INC·Filed 2007·Application pending·0 cites
- 0947US2007196491A1Drug delivery systems comprising weakly basic drugs and organic acidsEURAND INC·Filed 2007·Application pending·0 cites
- 1045US2011135724A1Ondansetron Orally Disintegrating Tablet Compositions for Prevention of Nausea and VomitingEURAND INC·Filed 2010·Application pending·0 cites
- 1144US2011256218A1Controlled release compositions comprising meclizine or related piperazine derivativesEURAND INC·Filed 2011·Application pending·0 cites
- 1237US2011212171A1Taste masked topiramate composition and an orally disintegrating tablet comprising the sameEURAND INC·Filed 2011·Application pending·0 cites
- 1333US2011129530A1Compressible-Coated Pharmaceutical Compositions and Tablets and Methods of ManufactureEURAND INC·Filed 2010·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →